Artificial Cell Constructs For Cellular Manipulation
AssigneesUniversity of Pittsburgh—Of the Commonwealth System of Higher Education, Massachusetts Institute of Technology
InventorSteven R. Little
Life of this patent
Estimating the term…
Loading patent…
AssigneesUniversity of Pittsburgh—Of the Commonwealth System of Higher Education, Massachusetts Institute of Technology
InventorSteven R. Little
Estimating the term…
The present invention contemplates induction of immunological tolerance thereby providing permanent allograft acceptance. This method obviates the need for a lifelong regimen of immunosuppressive agents which can increase the risk of infection, autoimmunity, and cancer. Immunological tolerance is thought to be mediated by regulatory T lymphocytes (Treg cells) with immunosuppressive capabilities. A therapeutically relevant platform comprising artificial constructs are contemplated comprising numerous soluble and surface bound Treg cell stimulating factors that may induce tolerance following allograft transplantation. Such artificial constructs, being the size of a cell, have surface bound monoclonal antibodies specific to regulatory T-cell surface moieties and encapsulated soluble regulatory T-cell modulating factors.
1-22. (canceled)
A method, comprising:
35-46. (canceled)
Dependencies are inferred from the claim text.